Search results
Results from the WOW.Com Content Network
Planar Systems, Inc. is an American digital display manufacturing corporation with a facility in Hillsboro, Oregon.Founded in 1983 as a spin-off from Tektronix, it was the first U.S. manufacturer of electroluminescent (EL) digital displays.
Leyard Optoelectronic (Chinese: 利亚德光电集团) is a publicly traded Beijing based electronics manufacturer, producing LED products including displays and lighting. Its main business segment is in screen displays of very large dimensions.
Single 20 to 40 mg oral doses generally give rise to peak plasma esomeprazole concentrations of 0.5-1.0 mg/L within 1–4 hours, but after several days of once-daily administration, these levels may increase by about 50%. A 30-minute intravenous infusion of a similar dose usually produces peak plasma levels on the order of 1–3 mg/L. The drug ...
2023 US News & World Report rankings for Mayo Clinic Jacksonville [11] Specialty Rank (In the U.S.) Score (Out of 100) Cancer #27 68.8 Cardiology #29 65.7
Mayo Clinic Health System's Eau Claire hospital was ranked number 6 in the state of Wisconsin in 2020, and 4th in 2021 by U.S. News & World Report. [44] In 2021 and 2022, the health system's Albert Lea-Austin hospital, and La Crosse hospital were included in Newsweek 's list of top U.S. hospitals.
One of the most notable scientific papers that first popularized hydroxychloroquine as a COVID-19 treatment was retracted from its journal due to ethical and methodological issues. Retractions in ...
Pantoprazole, sold under the brand name Protonix, among others, is a medication used for the treatment of stomach ulcers, short-term treatment of erosive esophagitis due to gastroesophageal reflux disease (GERD), maintenance of healing of erosive esophagitis, and pathological hypersecretory conditions including Zollinger–Ellison syndrome.
For example, breast cancer patients of fertile age oftentimes have to weigh the risks and benefits associated with starting an adjuvant therapy regimen after primary treatment. In the some low-risk, low-benefit situations, forgoing adjuvant treatment altogether can be a reasonable decision, but in cases where the risk of metastasis is high ...